| Items | Drug Registration information |
|---|---|
| ID | 980 |
| No | 980 |
| Brand Name | PHOLENVA 4 |
| Ingredients | LENVATINIB 4 MG |
| Dosage Form | CAPSULE |
| Primary Packaging | BLISTERPACK |
| Storage | |
| Shelf Life | 3 YEARS |
| Pack Size | BOX OF 3 X 10'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE-YELLOW CAPSULE CONTAINING WHITE GRANULES |
| Note | |
| License Owner | FACTORY NO.2 |
| Manufacturer | FACTORY NO. 2 |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 02 L 0823/20 |
| FDD Registration Date | 29/08/2023 |
| Expiry Date | 28/08/2026 |